HSA — authorised 19 October 2016
- Marketing authorisation holder: ELI LILLY AND CO
- Status: likely_approved
HSA authorised Lartruvo on 19 October 2016
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. HSA authorised it on 19 October 2016.
ELI LILLY AND CO holds the Singaporean marketing authorisation.